{"DataElement":{"publicId":"3871888","version":"1","preferredName":"Malignant Neoplasm Fludeoxyglucose F 18 Positron Emission Tomography Uptake Assessment Finding Scale","preferredDefinition":"The FDG PET uptake scale review results pertaining to a lesion's FDG PET assessment.","longName":"LsnFDGPETUptakeScale","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"3871876","version":"1","preferredName":"Malignant Neoplasm Fludeoxyglucose F 18 Positron Emission Tomography Uptake Assessment Finding","preferredDefinition":"information related to the uptake or abosorbtion of Fludeoxyglucose F 18 (FDG), the radioactive form of glucose used in positron emission tomography (PET) assessment, of a malignant neoplasm, a tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.","longName":"LsnFDGPETUptake","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"2186369","version":"1","preferredName":"Malignant Neoplasm","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","longName":"C9305","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E0647F5B-A888-4B87-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-08-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-08-03","modifiedBy":"DATA_LOADER","dateModified":"2005-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3871874","version":"1","preferredName":"Fludeoxyglucose F 18 Positron Emission Tomography Uptake Assessment Finding","preferredDefinition":"The radioactive form of glucose used in positron emission tomography (PET), a diagnostic imaging procedure.:A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered.:The absorption by a tissue of some substance, food material, mineral, etc., and its permanent or temporary retention.:Having determined the value, significance, or extent of.:Clinical, laboratory or molecular evidence, or absence of evidence of disease. ","longName":"3871874v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fludeoxyglucose F-18","conceptCode":"C964","definition":"A positron-emitting radiopharmaceutical containing radioactive 2-deoxy-2-[18F] fluoro-D-glucose. With similar cell uptake as glucose (high in tumor cells), fludeoxyglucose F 18 is not dephosphorylated and further metabolized. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Positron Emission Tomography","conceptCode":"C17007","definition":"A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Uptake","conceptCode":"C71688","definition":"The absorption by a tissue of some substance, food material, mineral, etc., and its permanent or temporary retention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Finding","conceptCode":"C3367","definition":"Clinical, laboratory or molecular evidence, or absence of evidence of disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5328507-4DD8-E213-E040-BB89AD434BBE","latestVersionIndicator":"Yes","beginDate":"2013-08-30","endDate":null,"createdBy":"BEELEST","dateCreated":"2013-08-30","modifiedBy":"ONEDATA","dateModified":"2013-08-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5328507-4DE9-E213-E040-BB89AD434BBE","latestVersionIndicator":"Yes","beginDate":"2013-08-30","endDate":null,"createdBy":"BEELEST","dateCreated":"2013-08-30","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":" Changed from CTEP to COG for by script Thu Jan 2 10:00:57 EST 2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3871880","version":"1","preferredName":"FDG Uptake Scale","preferredDefinition":"Scale of FDG PET uptake review findings.","longName":"FDGUptakeScale","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"99","valueDescription":"99. Not Applicable","ValueMeaning":{"publicId":"3871881","version":"1","preferredName":"99. Not Applicable","longName":"3871881","preferredDefinition":"99. Not Applicable","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E532E70B-3788-6C19-E040-BB89AD431DAB","latestVersionIndicator":"Yes","beginDate":"2013-08-30","endDate":null,"createdBy":"BEELEST","dateCreated":"2013-08-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E532E70B-37A1-6C19-E040-BB89AD431DAB","beginDate":"2013-08-30","endDate":null,"createdBy":"BEELEST","dateCreated":"2013-08-30","modifiedBy":"ONEDATA","dateModified":"2013-08-30","deletedIndicator":"No"},{"value":"5","valueDescription":"5. Markedly increased compared to liver","ValueMeaning":{"publicId":"3871882","version":"1","preferredName":"5. Markedly increased compared to liver","longName":"3871882","preferredDefinition":"5. Markedly increased compared to liver","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E532E70B-37AB-6C19-E040-BB89AD431DAB","latestVersionIndicator":"Yes","beginDate":"2013-08-30","endDate":null,"createdBy":"BEELEST","dateCreated":"2013-08-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E532E70B-37C4-6C19-E040-BB89AD431DAB","beginDate":"2013-08-30","endDate":null,"createdBy":"BEELEST","dateCreated":"2013-08-30","modifiedBy":"ONEDATA","dateModified":"2013-08-30","deletedIndicator":"No"},{"value":"4","valueDescription":"4. Moderately increased compared to liver","ValueMeaning":{"publicId":"3871883","version":"1","preferredName":"4. Moderately increased compared to liver","longName":"3871883","preferredDefinition":"4. Moderately increased compared to liver","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E532E70B-37CE-6C19-E040-BB89AD431DAB","latestVersionIndicator":"Yes","beginDate":"2013-08-30","endDate":null,"createdBy":"BEELEST","dateCreated":"2013-08-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E532E70B-37E7-6C19-E040-BB89AD431DAB","beginDate":"2013-08-30","endDate":null,"createdBy":"BEELEST","dateCreated":"2013-08-30","modifiedBy":"ONEDATA","dateModified":"2013-08-30","deletedIndicator":"No"},{"value":"3","valueDescription":"3. Greater than mediastinal blood pool and less than or equal to liver","ValueMeaning":{"publicId":"3871884","version":"1","preferredName":"3. Greater than mediastinal blood pool and less than or equal to liver","longName":"3871884","preferredDefinition":"3. Greater than mediastinal blood pool and less than or equal to liver","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E532E70B-37F1-6C19-E040-BB89AD431DAB","latestVersionIndicator":"Yes","beginDate":"2013-08-30","endDate":null,"createdBy":"BEELEST","dateCreated":"2013-08-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E532E70B-380A-6C19-E040-BB89AD431DAB","beginDate":"2013-08-30","endDate":null,"createdBy":"BEELEST","dateCreated":"2013-08-30","modifiedBy":"ONEDATA","dateModified":"2013-08-30","deletedIndicator":"No"},{"value":"2","valueDescription":"2. Less than or equal to mediastinal blood pool","ValueMeaning":{"publicId":"3871885","version":"1","preferredName":"2. Less than or equal to mediastinal blood pool","longName":"3871885","preferredDefinition":"2. Less than or equal to mediastinal blood pool","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E532E70B-3814-6C19-E040-BB89AD431DAB","latestVersionIndicator":"Yes","beginDate":"2013-08-30","endDate":null,"createdBy":"BEELEST","dateCreated":"2013-08-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E532E70B-382D-6C19-E040-BB89AD431DAB","beginDate":"2013-08-30","endDate":null,"createdBy":"BEELEST","dateCreated":"2013-08-30","modifiedBy":"ONEDATA","dateModified":"2013-08-30","deletedIndicator":"No"},{"value":"1","valueDescription":"1. No uptake above surround background","ValueMeaning":{"publicId":"3871886","version":"1","preferredName":"1. No uptake above surround background","longName":"3871886","preferredDefinition":"1. No uptake above surround background","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E532E70B-3837-6C19-E040-BB89AD431DAB","latestVersionIndicator":"Yes","beginDate":"2013-08-30","endDate":null,"createdBy":"BEELEST","dateCreated":"2013-08-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E532E70B-3850-6C19-E040-BB89AD431DAB","beginDate":"2013-08-30","endDate":null,"createdBy":"BEELEST","dateCreated":"2013-08-30","modifiedBy":"ONEDATA","dateModified":"2013-08-30","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2452834","version":"1","preferredName":"Scale","preferredDefinition":"an ordered reference standard.","longName":"C25664","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Scale","conceptCode":"C25664","definition":"An ordered reference standard used to measure incremental changes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"0D51E8D8-69DD-387C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-02-24","modifiedBy":"ONEDATA","dateModified":"2006-02-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E532E70B-3774-6C19-E040-BB89AD431DAB","latestVersionIndicator":"Yes","beginDate":"2013-08-30","endDate":null,"createdBy":"BEELEST","dateCreated":"2013-08-30","modifiedBy":"SBR","dateModified":"2014-01-02","changeDescription":" Changed from CTEP to COG for by script Thu Jan 2 10:00:57 EST 2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"3303197","version":"1","longName":"Phase 1/Pilot Consortium","context":"COG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Lesion FDG PET Uptake","type":"Preferred Question Text","description":"Lesion FDG PET Uptake","url":null,"context":"CTEP"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E532E70B-3886-6C19-E040-BB89AD431DAB","latestVersionIndicator":"Yes","beginDate":"2013-08-30","endDate":null,"createdBy":"BEELEST","dateCreated":"2013-08-30","modifiedBy":"SBR","dateModified":"2014-01-02","changeDescription":" Changed from CTEP to COG for by script Thu Jan 2 10:00:57 EST 2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}